• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复苏液的生物物理特性。

Biophysical properties of resuscitation fluids.

作者信息

Cerny L C, Stasiw D M, Cerny E L

出版信息

Crit Care Med. 1982 Apr;10(4):254-60. doi: 10.1097/00003246-198204000-00004.

DOI:10.1097/00003246-198204000-00004
PMID:7067475
Abstract

The preliminary results of this study indicate that the biophysical characteristics of stroma-free hemoglobin solution (SFH) make it an extremely suitable blood substitute. At the concentration that is currently being considered as an infusing solution (70 g/L), it is a Newtonian fluid having a viscosity very similar to that of plasma. At this concentration, SFH also has very favorable hemodilution properties, as well as potential oxygen transport ability, which most expanders lack. There seems to be little interaction between the plasma proteins and SFH, as indicated from viscosity measurements. The osmotic behavior of SFH indicates that it approaches an ideal polymer-solvent system as illustrated by the small value of the second virial coefficient, especially when compared to other plasma substitutes. In mixtures with whole blood at a series of hematocrits, SFH seems to be hyperosmotic. This biophysical property could certainly have significance in patients with severe shock. SFH maintains the integrity of whole blood and does not initiate erythrocyte aggregation. The investigations of the erythrocyte sedimentation rate (ESR) in this study with SFH indicate the potential usefulness of SFH in maintaining stability of these systems, particularly during the treatment of shock. The transport properties of the red cell membrane are apparently not effectively altered by the presence of SFH. This has been illustrated in the hemolytic malonamide kinetic and osmotic fragility studies. Although the results are preliminary, it should be stressed that SFH may offer protection against hemolysis when used as a transfusion solution.

摘要

本研究的初步结果表明,无基质血红蛋白溶液(SFH)的生物物理特性使其成为一种极其合适的血液替代品。在目前被视为输注溶液的浓度(70 g/L)下,它是一种牛顿流体,其粘度与血浆非常相似。在此浓度下,SFH还具有非常良好的血液稀释特性以及潜在的氧运输能力,而这是大多数扩容剂所缺乏的。粘度测量结果表明,血浆蛋白与SFH之间似乎几乎没有相互作用。SFH的渗透行为表明,它接近理想的聚合物 - 溶剂体系,如第二维里系数的值较小所示,特别是与其他血浆替代品相比时。在一系列血细胞比容下与全血混合时,SFH似乎具有高渗性。这种生物物理特性在严重休克患者中肯定具有重要意义。SFH维持全血的完整性,不会引发红细胞聚集。本研究中对SFH的红细胞沉降率(ESR)的研究表明,SFH在维持这些系统的稳定性方面具有潜在用途,特别是在休克治疗期间。SFH的存在显然没有有效改变红细胞膜的转运特性。这已在溶血丙二酰胺动力学和渗透脆性研究中得到证明。虽然结果是初步的,但应该强调的是,SFH用作输血溶液时可能提供抗溶血保护。

相似文献

1
Biophysical properties of resuscitation fluids.复苏液的生物物理特性。
Crit Care Med. 1982 Apr;10(4):254-60. doi: 10.1097/00003246-198204000-00004.
2
Mixtures of whole blood and hydroxyethyl starch--hemoglobin polymers.全血与羟乙基淀粉 - 血红蛋白聚合物的混合物。
Crit Care Med. 1983 Sep;11(9):739-43. doi: 10.1097/00003246-198309000-00014.
3
Mixtures of erythrocytes and acellular fluids: an in vitro evaluation.红细胞与无细胞液的混合物:一项体外评估
Artif Cells Blood Substit Immobil Biotechnol. 1994;22(3):633-9. doi: 10.3109/10731199409117893.
4
Polymerized pyridoxylated hemoglobin: a red cell substitute with normal oxygen capacity.聚合吡哆醛化血红蛋白:一种具有正常氧容量的红细胞替代物。
Surgery. 1984 Apr;95(4):433-8.
5
Peritoneal accumulation of infused stroma-free hemoglobin. Potential toxicity of an oxygen-carrying substitute.输注的无基质血红蛋白在腹膜的蓄积。一种携氧替代物的潜在毒性。
Arch Surg. 1987 Mar;122(3):355-7. doi: 10.1001/archsurg.1987.01400150109021.
6
Oxygen-transporting fluids and oxygen delivery with hemodilution.氧输送液与血液稀释时的氧输送
Crit Care Med. 1982 Apr;10(4):270-4. doi: 10.1097/00003246-198204000-00007.
7
The efficacy of polymerized pyridoxylated hemoglobin solution as an O2 carrier.聚合吡哆醛化血红蛋白溶液作为氧载体的疗效。
Ann Surg. 1990 Apr;211(4):394-8. doi: 10.1097/00000658-199004000-00003.
8
Polymerized pyridoxylated hemoglobin: efficacy as an O2 carrier.
J Trauma. 1986 Oct;26(10):903-8. doi: 10.1097/00005373-198610000-00007.
9
Artificial blood: current status of hemoglobin solutions.
Crit Care Clin. 1992 Apr;8(2):293-309.
10
Red cell substitutes: hemoglobin solution or fluorocarbon?红细胞替代物:血红蛋白溶液还是氟碳化合物?
J Trauma. 1982 Sep;22(9):736-40.